Adalimumab 83012-0013
Product NDC
83012-0013- Manufacturer
- Boehringer Ingelheim Fremont, Inc.
- Dosage Form
- Liquid
- Product Type
- Drug For Further Processing
- Marketing Start
- March 18, 2022
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Adalimumab-Adbm | 10 mg/.2mL |
Packaging Options(1)
1 mL in 1 SYRINGE (83012-013-10)